Mycoplasma pneumoniae is a common cause of community-acquired infections of the human respiratory tract. The strongly reduced genome of the cell wall-less bacteria results in limited metabolic pathways and a small number of known virulence factors. In addition to the well-characterized adhesion apparatus and the expression of tissue-damaging substances, surface-exposed proteins with a primary function in cytosol-located processes such as glycolysis have been attracting attention in recent years. Due to interactions with host factors, it has been suggested that these bacterial proteins contribute to pathogenesis. Here, we investigated the chaperones GroEL and DnaK of M. pneumoniae as candidates for such moonlighting proteins. After successful expression in Escherichia coli and production of polyclonal antisera, the localization of both chaperones on the surface of bacteria was confirmed. Binding of recombinant GroEL and DnaK to human A549 cells, to plasminogen as well as to vitronectin, fibronectin, fibrinogen, lactoferrin and laminin was demonstrated. In the presence of both recombinant proteins and host activators, plasminogen can be activated to the protease plasmin, which is able to degrade vitronectin and fibrinogen. The results of the study extend the spectrum of surface-exposed proteins in M. pneumoniae and indicate an additional role of both chaperones in infection processes.
INTRODUCTION
The cell wall-less members of the genus Mycoplasma are commensal, opportunistic or pathogenic bacteria that can colonize plants, animals and humans. Among them, Mycoplasma pneumoniae is a pathogen causing a broad range of infections of the human respiratory tract. During epidemics, which occur every 3 to 7 years, up to 40% of all cases of community-acquired pneumonia are attributed to these bacteria (Atkinson, Balish and Waites 2008) . Additionally, a number of extrapulmonary manifestations and complications of infections have been reported in recent years affecting mainly the skin and the central nervous system (Narita 2016) . In the course of evolutionary adaptation to a parasitic lifestyle in the respiratory mucosa, M. pneumoniae cells strongly reduced their genomic capacities (816 kbp in reference strain M129) with the consequence of limited metabolic pathways (Kühner et al. 2009 ). Furthermore, in comparison to other bacteria with pathogenic potential, the number of known virulence factors is small. These include the tip-structured adhesion complex (Hasselbring et al. 2006) as well as expression of substances damaging the epithelium of the respiratory tract such as hydrogen peroxide (Hames et al. 2009 ), hydrogen sulfide (Großhennig et al. 2016 ) and the CARDS toxin (Kannan and Baseman 2006), respectively. As described for numerous bacterial species, proteins with primary cytosol-located function might be transported by an unknown mechanism to the surface of the cells (Henderson 2014) . In this location, many proteins are able to interact with host factors like plasminogen (Plg) or components of the complement system and of the extracellular matrix (ECM). By influencing important processes such as cell adhesion, tissue integrity and escape of the host immune system, it is argued that these interactions contribute to pathogenesis (Henderson and Martin 2011) . Glycolytic enzymes mainly have been characterized as typical members of this class of proteins with dual function. Recently, eight glycolytic enzymes of M. pneumoniae were found to be surface displayed and interacting with human Plg or different ECM proteins (Gründel, Jacobs and Dumke 2016) . Moreover, results of previous studies have shown that further classes of bacterial proteins are involved in these processes. Dallo et al. (2002) demonstrated the surface location of the elongation factor thermo unstable (EF-Tu) of M. pneumoniae and confirmed the interaction of the protein with human fibronectin (Fc). Furthermore, stress-related proteins such as GroEL and DnaK were identified as cell wall associated or surface located in different bacterial species with and without pathogenic properties such as Vibrio cholerae (Jyot et al. 1999) , Listeria monocytogenes (Schaumburg et al. 2004) , Neisseria menigitidis (Knaust et al. 2007) , Mycobacterium tuberculosis (Xolalpa et al. 2007) , M. smegmatis (He and de Buck 2010a) and M. avium subsp. paratuberculosis (He and de Buck 2010b) , Bifidobacterium animalis subsp. lactis (Candela et al. 2010) , Lactobacillus casei (Muñoz-Provencio, Pérez-Martínez and Monedero 2011), Streptococcus suis (Zhang et al. 2014) and Escherichia coli (Moraes et al. 2015) , respectively. Interactions with human collagen, Fc and/or Plg were demonstrated for many of these heat-shock proteins.
Among Mycoplasma species, the possible role of chaperones as surface-displayed multifunctioning proteins has been poorly studied. However, GroEL was characterized as occurring in the membrane protein fraction of M. gallisepticum (Tan et al. 2015) and DnaK was identified as antigen for serological diagnosis of feline hemotrophic Mycoplasma infections (Wolf-Jäckel et al.
2010
). Regarding M. pneumoniae, systemic antibodies to GroEL were detected in infected patients but with relatively low prevalence (Bencina, Slavec and Narat 2005) . Furthermore, DnaK was found complexed with the membrane-associated P1 adhesin (Layh-Schmitt, Podtelejnikov and Mann 2000) , and DnaK and GroEL were determined in the fraction of Triton X-100-insoluble proteins (Regula et al. 2001) , which have been regarded as components of the cytoskeleton-like structures of the microorganism. Taking these data together, GroEL and DnaK are further candidates for surface-exposed proteins. In this study, we examined the location of both proteins and their associations with selected host factors to contribute to a more comprehensive picture of M. pneumoniae proteins with primarily regulatory or metabolic activity in host-pathogen interaction.
MATERIALS AND METHODS

Bacterial strains and human cells
The Mycoplasma pneumoniae strain M129 (ATCC 29342, the Escherichia coli strains NovaBlue and BL21(DE3) (Novagen, Darmstadt, Germany) and A549 cells (human lung carcinoma cell line ATCC CCL-185) were propagated as described (Schurwanz, Jacobs and Dumke 2009) . Protein concentration was determined using the BCA protein assay kit (Pierce, Rockford, USA) as recommended by the manufacturer.
Recombinant production of DnaK and GroEL of Mycoplasma pneumoniae and polyclonal antibodies
Freshly grown adherent mycoplasmal cells were harvested using a cell scraper, and DNA was prepared with the QIAamp DNA Mini Kit (Qiagen, Hilden, Germany) as recommended by the manufacturer. Full-length genes coding for DnaK (mpn434 , Table 1) and GroEL (mpn573) were amplified using the primer pairs summarized in Table 2 . The single TGA codon in mpn434 was mutated to TGG by the multiple mutation reaction (MMR; Hames et al. 2005) . PCR products were purified and cloned into the pET-30/LIC vector (Novagen). Escherichia coli strains NovaBlue and BL21(DE3) were transformed as reported (Thomas, Jacobs and Dumke 2013) . Successful transformation and exchange of TGA were confirmed by PCR and sequencing. The E. coli clones containing the vectors with the genes coding for GroEL and DnaK of M. pneumoniae were used to express the N-terminal 6x Histagged proteins after induction with 1 mM isopropyl thiogalactoside (Sigma, St. Louis, MI, USA) for 5 h at 37
• C. The proteins were purified under native and denaturing conditions with Ninitrilotriacetic acid columns (Qiagen), concentrated with ultrafiltration spin columns (Sartorius, Göttingen, Germany) and the protein concentration was measured as described. Expression results were verified after separation of proteins by SDS-PAGE using 10% NuPage Bis-Tris gels (Life, Carlsbad, CA, USA) and Coomassie blue staining (Merck, Darmstadt, Germany) according to the standard procedures. Polyclonal antisera were produced in guinea pigs (Charles River, Sulzfeld, Germany). The animal experiments were approved by the ethical board of Landesdirektion Sachsen, Dresden, Germany (permit no. 24-9168.25-1/2011/1). Primary subcutaneous immunization of animals with recombinant proteins (purified under denaturing conditions), booster immunizations and serum collection were carried out as described (Thomas, Jacobs and Dumke 2013) . Specificity of the sera (1:500) was tested with total protein content of M. pneumoniae by immunoblotting and peroxidase-conjugated anti-guinea pig Ig (Dako, Hamburg, Table 2 . Oligonucleotides used in the study (underlined: vector-specific sequence; double underlined: mutation of TGA to TGG). Germany; 1:1 000). Reactivity of antisera with whole proteins was quantified by ELISA as described ) and compared with an antiserum obtained after immunization of guinea pig with M. pneumoniae whole proteins (primary antibodies: 1:500; secondary antibody: 1:1 000).
Localization of Mycoplasma pneumoniae GroEL and DnaK
Determination of the cellular localization of GroEL and DnaK was carried out using different approaches. The first indication of an association of both chaperones with the membraneassociated protein fraction of M. pneumoniae resulted from ELISA experiments using the cytosolic and membrane proteins as described . Briefly, mycoplasmal cells were fractionated by ultracentrifugation (Proft and Herrmann 1994) and both fractions (15 μg mL −1 ) were used to coat wells of 96-well plates (Greiner, Frickenhausen, Germany). After blocking (10% FCS) and washing, guinea pig antisera to GroEL and DnaK (1:500) and HRP-conjugated anti-guinea pig Ig (1:1 000) were added. Antisera to intracellular-and surface-located pyruvate dehydrogenase subunit B (PdhB; Thomas, Jacobs and Dumke 2013) , to intracellular NADH oxidase (Nox; Pollack, Williams and McElhaney 1997) , to the membrane-associated C-terminal part of P1 adhesin (P12; Schurwanz, Jacobs and Dumke 2009) and to whole proteins of M. pneumoniae acted as controls. The reactivity of antisera to GroEL and DnaK with freshly grown and fixed M. pneumoniae cells was tested by immunofluorescence as described (Thomas, Jacobs and Dumke 2013) . After incubation with a mixture of corresponding guinea pig antiserum (1:250) and rabbit antiserum to the of TX-100-insoluble protein fraction (cell staining control; 1:250), cells were treated with FITC-labeled anti-guinea pig and TRITC-labeled anti-rabbit antibodies (Sigma; 1:500). Guinea pig antisera to Nox and to recombinant protein P12 of M. pneumoniae were used as negative and positive controls, respectively.
For colony blotting, freshly grown bacteria were harvested as described, diluted with PBS and plated on PPLO agar plates. After incubation for 8 days at 37
• C, surface proteins of colonies were blotted onto nitrocellulose membranes (Schleicher and Schuell, Dassel, Germany) as described (Thomas, Jacobs and Dumke 2013) . Membranes were treated with antisera (1:250) to GroEL or DnaK, to Nox (negative control) and to recombinant protein P12 of M. pneumoniae (positive control), respectively. Detection was done with HRP-conjugated anti-guinea pig Ig (1:1 000). For further confirmation of surface accessibility of GroEL and DnaK, freshly grown M. pneumoniae cells (200 μg mL -1 ) were incubated with PBS and increasing concentrations of chymotrypsin (Sigma) as described . After separation of proteins by SDS-PAGE and blotting, membranes were treated with anti-GroEL and -DnaK (1:250), with anti-Nox (negative control) and anti-P12 (positive control). Detection of proteins and their degradation products was done with peroxidase-labeled antiguinea pig Ig (1:1 000).
Binding of recombinant proteins GroEL and DnaK to human A549 cells and influence of corresponding antisera on binding
To test the quantitative binding of recombinant proteins to A549 cells, a comparative ELISA was used as reported recently . Briefly, cells were harvested with a scraper, the protein concentration was adjusted to100 μg mL −1 PBS and the cells were immobilized in wells of an ELISA plate (2 h; 37
To test the maximal binding of GroEL and DnaK, parallel wells were coated with recombinant proteins (10 μg mL −1 ). Recombinant proteins PdhB (confirmed binding to A549 cells; and P08 (central part of the P1 protein with missing cell binding property; Schurwanz, Jacobs and Dumke 2009) were included as positive and negative controls. After blocking, recombinant proteins (10 μg mL −1 ) were added to wells with cells (2 h; 37 • C), whereas wells with immobilized recombinant proteins were treated in parallel with PBS. Recombinant proteins were determined with corresponding guinea pig antisera (1:750) and anti-guinea pig Ig (1:1 000). Viability of A549 during treatment was confirmed microscopically as reported . Specificity of binding of recombinant proteins to human cells was tested by preincubation with corresponding polyclonal antibodies. Freshly harvested A549 cells (100 μg mL −1 ) were immobilized in wells of ELISA plates (2 h; 37 • C). In parallel, recombinant proteins were preincubated with guinea pig antisera or a preimmune serum as negative control (each 1:100; 1.5 h; room temperature). After washing and blocking of cavities, mixtures were added. Bound proteins were detected as described.
Binding of recombinant proteins GroEL and DnaK to human Plg and selected ECM components and influence of ionic interactions and ε-aminocaproic acid on binding
The interaction of M. pneumoniae whole cells and of recombinant proteins with Plg and components of human ECM was analyzed as described previously . Briefly, wells of 96-well plates were coated with recombinant proteins and BSA as negative control. According to the results of preliminary binding experiments, increasing concentrations of human Plg (Sigma; 0, 1, 2.5, 5, 7.5 and 10 μg mL and 25 μg mL −1 PBS) were added (2 h; 37
were detected using the corresponding antisera (Sigma; rabbit anti-Plg: 1:2 500; rabbit anti-Vc: 1:5 000; goat anti-Fn: 1:3 000; rabbit anti-Fc 1:1 000; rabbit anti-Lf: 1:5 000; rabbit anti-Ln: 1:750) and anti-rabbit IgG (Dako; 1:2 000) or anti-goat IgG (Dako; 1:2 000). The influence of ionic interactions on the binding of recombinant proteins to Plg and ECM factors was determined as reported . Wells of ELISA plates were coated with recombinant GroEL and DnaK as described. Human Plg (2.5 μg mL −1 ) and selected ECM components (Lf: 0.5 μg mL −1 , Ln: 15 μg mL −1 , Fc: 65 μg mL −1 , Fn: 15 μg mL −1 , Vc: 0.1 μg mL −1 ) were diluted in PBS without and with increasing concentrations of NaCl (62.5, 250, 650 mM; Roth, Karlsruhe, Germany), added to the cavities with immobilized recombinant proteins and incubated (2 h; 37 • C). Bound Plg and ECM proteins were measured as described.
Additionally, the importance of lysine residues for Plg binding was investigated using the lysine analog ε-aminocaproic acid (ACA, Sigma). Recombinant proteins GroEL and DnaK, whole M. pneumoniae antigen and BSA (negative control) were immobilized in wells of ELISA plates. After washing and blocking, Plg (2.5 μg mL −1 ) in PBS without and with increasing concentrations of ACA (1, 5 and 10 mM) was added to the wells and incubated (1.5 h, 37
• C). Detection of bound Plg was done as described above.
Activation of human Plg in the presence of GroEL and DnaK of Mycoplasma pneumoniae and degradation of ECM proteins
The activation of Plg to the protease plasmin in the presence of GroEL and DnaK was tested by a modified quantitative assay . Cavities of 96-well plates were coated with recombinant proteins GroEL, DnaK, PdhB (positive control: confirmed Plg-binding protein; or BSA (negative control: non-Plg-binding protein), respectively. After washing and blocking, human Plg (10 μg mL −1 ), urokinase plasminogen activator (uPA) or tissue plasminogen activator (tPA; both Millipore, Billerica, MA; 4 ng/well) and the plasmin-specific substrate D-valyl-leucyl-lysine-p-nitroanilide dihydrochloride (0.75 mM; Sigma) were added and incubated at 37 • C. Controls without Plg were prepared in parallel. After different incubation times, samples were taken and signals were measured at 405 nm. Furthermore, to test the influence of human cells on plasmin generation, freshly harvested A549 cells (100 μg mL −1 ) were added to the mixture and incubated as described. The proteolytic activity of generated plasmin to cleave the selected human ECM components was tested as reported recently . Briefly, recombinant proteins (purified under denaturing conditions) and BSA as negative control were used to coat wells of an ELISA plate. After washing and blocking, proteins were incubated with human Plg (10 μg mL −1 ; 2 h, 37
• C). Subsequently, the ECM components Vc, Fn, Fc, Lf and Ln (15 μg mL −1 each) and tPA or uPA (75 ng/well) were added.
Parallel wells without Plg acted as controls. Plates were stored at 37
• C. Samples were taken after 0 and 24 h, protein sample buffer was added and the reaction was stopped (96 • C; 10 min).
Proteins were separated by SDS-PAGE and blotted on a nitrocellulose membrane as described above. Human ECM proteins were detected with the corresponding primary antibodies (1:3 000) and peroxidase-conjugated secondary antibodies (1:2000).
RESULTS
Expression of recombinant proteins and reactivity of corresponding antisera
After successful exchange of the single TGA codon (coding for tryptophan in mycoplasmas) in the gene encoding for the chaperone DnaK (Table 1) to circumvent the stop of translation in Escherichia coli, the complete genes mpn434 and mpn573 of Mycoplasma pneumoniae were cloned into the pET-30/LIC vector. Overexpressed proteins were purified under native as well as denaturing conditions and analyzed by SDS-PAGE. Coomassie staining of the gels demonstrated prominent protein bands with the expected molecular mass (Fig. 1A) . Recombinant proteins were used to produce guinea pig polyclonal antisera. The specificity of the antibodies obtained was tested with total proteins of M. pneumoniae in immunoblotting and resulted in exclusive bands matching the predicted molecular masses of GroEL and DnaK, respectively (Fig. 1B) . In a comparative ELISA, the reactivities of anti-GroEL, anti-DnaK and an antiserum against total proteins of M. pneumoniae were measured. OD values of antisera to GroEL and to total proteins are comparable, whereas the antiserum to DnaK reacted significantly more weakly (Fig. 1C) . Antibody titration of both sera using the corresponding recombinant proteins resulted in comparable values (anti-GroEL: log 4.9 vs. anti-DnaK: log 4.3) indicating differences in the concentrations of proteins among total proteins. However, the specificity of the antisera and the occurrence of detectable concentrations of both proteins among the total protein content of M. pneumoniae were confirmed.
Surface localization of GroEL and DnaK
The first evidence for localization of chaperones GroEL and DnaK in the M. pneumoniae cell resulted from the ELISA reactivity of corresponding antisera with the membrane and cytosolic protein fractions of whole cells (Fig. 2A) . The antiserum to GroEL showed high OD values with both protein fractions, comparable to the signals obtained with antisera to total proteins as well as to the glycolytic enzyme PdhB, which was confirmed in a previous report as occurring in both fractions ).
In comparison with GroEL, DnaK was also detected in both protein fractions but with significantly lower OD values (cytosolic proteins: 1.99 vs. 1.16; membrane-associated proteins: 1.16 vs. 0.29). As control for a predicted cytosolic protein, Nox yielded a low OD value (< 0.2) with the membrane-associated protein fraction but gave a clear signal with the cytosolic proteins. In contrast, antisera to the confirmed surface-exposed part (P12) of the membrane protein P1 resulted in low reactivity with the cytosolic protein fraction but a high OD value with the membrane protein fraction. Surface accessibility of GroEL and DnaK was analyzed by immunofluorescence, colony blotting and mild proteolysis of M. pneumoniae cells (Fig. 2B-D) . In immunofluorescence and colony blot, strong signals were detected after incubation of blot and fixed cells with antisera to both chaperones and to the part of the P1 adhesin (P12). Additionally, increasing degradation of GroEL and DnaK was found after treatment of bacteria with increasing concentrations of chymotrypsin. Control experiments with the intracellular Nox remained negative in colony blot as well as in the immunofluorescence assay, and the protein was stable to protease treatment. In contrast, the C-terminal part of P1 adhesin (positive control) was degradable and staining of colonies and strong immunofluorescence of M. pneumoniae cells were demonstrated after incubation with the corresponding antiserum, confirming the surface localization of this protein. Experiments with guinea pig pre-immune serum remained negative in all approaches, excluding an influence of non-specific cross-reactions on the results (data not shown). From the overall data, surface exposure of both chaperones GroEL and DnaK on the M. pneumoniae cells was assumed.
Binding of recombinant GroEL and DnaK to human A549 cells
The ability of recombinant proteins to bind to immobilized A549 cells was tested in ELISA experiments and compared with the OD values obtained after parallel incubation of antisera to both chaperones with immobilized recombinant proteins without cells (Fig. 3A) . As expected, the confirmed control of a strong cellbinding protein (PdhB; (Fig. 3B ). In comparison with the results of pretreatment of proteins with guinea pig preimmune serum, incubation with monospecific antisera reduced the mean binding significantly by 77% (GroEL), 60% (DnaK) and 26% (control PdhB), respectively. As expected, treatment with preimmune and specific antiserum of non-cell-binding protein P08 resulted in comparable mean OD values below 0.2. No significant difference in binding to A549 cells between recombinant proteins purified under native and denaturing conditions was found (data not shown).
Interaction of recombinant GroEL and DnaK with human Plg and ECM proteins
After confirmation of binding of recombinant proteins to A549 cells, interactions with specific host components were investigated. By using selected human proteins, concentrationdependent binding to recombinant GroEL or DnaK, to whole proteins of M. pneumoniae M129 (positive control) and to BSA (negative control) was proven in ELISA experiments (Fig. 4) . In general, binding of any host component to BSA was not demonstrated. In contrast, interaction of all six human proteins with whole M. pneumoniae proteins and with both recombinant proteins was confirmed. However, the amount of bound host factor and achievement of a saturation level of bound protein depend on the binding partners involved. As expected, the strongest binding was measured with whole M. pneumoniae proteins and Plg, Fc, Lc and Ln, respectively. In most cases (with the exception of Plg), association of these human components with recombinant GroEL or DnaK is significantly lower and differences between the binding activities of both chaperones are relatively small. Interestingly, when using human Vc and Fn, higher OD values were demonstrated after interaction with recombinant GroEL compared with whole proteins. According to the importance of the surface accessibility of defined lysine residues for binding to Plg (Bergmann et al. 2003; Cork et al. 2009 ), an influence of purification of recombinant proteins on this interaction could not be excluded. Nevertheless, investigation of both protein preparations resulted in a comparable binding of Plg.
To further investigate the mechanisms underlying the interactions between recombinant proteins and host factors, the influence of ionic forces on binding was tested. Range of salt concentrations was selected according to previous studies and includes the normal blood concentration (about 150 mM). After adding increasing concentrations of NaCl to the reactions of GroEL or DnaK with human Plg and components of the ECM, a differentiated pattern of results was found (Fig. 5A) . Binding of both M. pneumoniae-specific recombinant proteins and whole proteins to Plg, Vc, Lc and Ln decreased with increased concentrations of NaCl. In the presence of the highest concentration of NaCl (650 mM), reductions in mean OD values of 27 to 68% (GroEL) and 37 to 59% (DnaK) were obtained compared with the control without addition of NaCl. In contrast, a significant influence of ions on interactions with human Fc was not demonstrated. Interestingly, binding of recombinant protein GroEL and whole proteins to Fn remains unchanged after adding NaCl whereas the interaction of DnaK depends clearly on the presence of salt. Differences between recombinant proteins prepared under denaturing and native conditions in the influence of ions on binding were not demonstrated (data not shown). The results underline the significance of ionic interactions for most of the associations between both chaperones and the host factors investigated but also indicate that additional mechanisms are responsible for binding.
A specific molecular mechanism of protein-protein interaction is the binding of Kringle domains of Plg with lysine residues of microbial partners. Overall, lysine accounts for 9.2% (GroEL) and 8.4% (DnaK) of the amino acids of both chaperones of M. pneumoniae. By occupying the binding sites with the analog ACA, lysine-dependent binding of recombinant proteins GroEL and DnaK to human Plg might be influenced. With ELISA experiments, it was shown here that OD values of bound Plg were reduced significantly by 56 to 87% (GroEL) and 67 to 82% (DnaK) in the presence of increasing concentrations of ACA (1-10 mM), compared with binding without ACA (Fig. 5B) . A comparable result was obtained using whole proteins of M. pneumoniae confirming the importance of lysine residues of both recombinant proteins and other mycoplasmal proteins for interaction with Plg. In parallel experiments, the influence of ACA on binding of recombinant proteins purified under native conditions to Plg was tested and no difference to those prepared under denaturing conditions was found (data not shown).
Activation of human Plg and degradation of ECM components in the presence of recombinant GroEL or DnaK of Mycoplasma pneumoniae
Generation of proteolytically active plasmin from inactive Plg is an important aspect of different host physiology processes. After confirmation of Plg binding of M. pneumoniae-specific recombinant proteins, the question still remains as to whether plasmin is generated in the presence of GroEL or DnaK and host activators uPA or tPA. Time-dependent formation of plasmin was measured in ELISA experiments. In negative controls without Plg, OD values during the incubation period of 7 h remained permanently below 0.1 with both activators. Using uPA and Plg, the presence of recombinant proteins GroEL, DnaK and PdhB (positive control; resulted in generation of comparable amounts of plasmin. After adding tPA to Plg and recombinant proteins, significantly earlier and higher generation of plasmin was demonstrated in the presence of PdhB compared with GroEL and DnaK (Fig. 6A) . No differences in OD values were obtained between both recombinant chaperones but plasmin generation was lower than in experiments with uPA. Interestingly, the presence of the three M. pneumoniae-specific recombinant proteins led to higher production of plasmin compared to parallels with control BSA, which showed no ability for Plg binding. Plasmin generation after use of recombinant proteins purified under native conditions was comparable to that in the presence of proteins prepared under denaturing conditions (data not shown). In additional experiments, the influence of co-incubated but not immobilized A549 cells on plasmin generation was tested (Fig. 6B) . All further components of the reaction remained as described. Controls without Plg demonstrated OD values < 0.2 (data not shown). In the presence of uPA, comparable OD values were measured in the presence of recombinant proteins GroEL, DnaK, PdhB and control protein BSA. Using tPA instead of uPA, in comparison to recombinant proteins higher plasmin production was found in the presence of BSA after more than 3 h of incubation.
Plasmin generation is the precondition for cleavage processes that are described for different components of the human ECM. To test the possibility of degradation of the host factors selected in this study, human Plg was bound to recombinant proteins GroEL or DnaK, unbound Plg was washed away and ECM components as well as activator were added. After incubation, proteins were separated by SDS-PAGE and blotted, and ECM factors were detected with corresponding antisera. No cleavage was demonstrated with human Fc, Lc and Ln (data not shown). In the presence of positive control PdhB , the heavy chain of Fn was degraded with uPA and tPA (Fig. 7A) . Using recombinant proteins GroEL and DnaK, this degradation was confirmed in the presence of uPA only. In contrast, the 75 kDa part of human Vc dimer was not further detectable after incubation with GroEL, DnaK and both activators (Fig. 7B) . In all cases, investigation of proteins at the start of the experiments and controls with BSA or without Plg resulted in the absence of cleavage of Fn and Vc.
DISCUSSION
GroEL and DnaK play a primary role in the network of chaperones that facilitate the folding of newly synthesized proteins to functional molecules (Sala, Bordes and Genevaux 2014) . In recent years, many reports have confirmed the cell surface display or secretion of bacterial chaperones and have suggested that these proteins have an additional function in infection processes (Henderson, Allan and Coates 2006) . Thus, bacterial chaperones are thought to belong to the different classes of mainly cytosol-localized proteins of bacteria with a primary role in regulation of cellular processes or biosynthesis, contributing to hostpathogen interaction when they occur extracellularly. These multifunctioning proteins include metabolic enzymes such as those of glycolysis and the tricarboxylic acid cycle, but proteins of other functional groups have also been described in non-pathogenic and pathogenic microbial species (Henderson 2014) . Among the latter, some members of the genus Mycoplasma are bacteria of high importance for human and animal health. Because of their reduced genomes, protein multifunction can be a way for these microorganisms to use limited resources effectively. In addition, the absence of the classical cell wall in mycoplasmas indicates an interesting difference regarding the structural association of surface-displayed proteins compared with all other bacterial species and confirms a general mechanism of protein localization not linked necessarily to the presence of a cell wall.
In the human pathogen Mycoplasma pneumoniae, the first report of multifunctioning cytosolic proteins demonstrated EF-Tu and PdhB as surface-localized interaction partners of human Fc (Dallo et al. 2002) . Recently, eight surface-displayed glycolytic enzymes of M. pneumoniae have been identified that are able to bind to one or more host factors such as Plg and ECM components Gründel, Jacobs and Dumke 2016) . The description of chaperones GroEL and DnaK as moonlighting proteins in other bacterial species and their occurrence among the membrane-associated protein fraction of M. pneumoniae (Regula et al. 2001) suggests that both chaperones have additional functions. Using different approaches in this study, we confirmed the localization of the proteins on the surface of mycoplasmal cells. Additionally, recombinant GroEL and DnaK show in vitro binding to human cells and to defined host factors. These selected factors have always been confirmed as occurring on the surface of A549 cells (Gründel, Jacobs and Dumke 2016) , indicating that the influence of the protein-protein interactions is important for colonization of the respiratory epithelium with M. pneumoniae. A549 cells were chosen according to their origin and stable growth. Like surface-displayed glycolytic enzymes such as GapA and PdhB, both chaperones are able to interact not only with human Plg but also with different ECM components. Thus, GroEL and DnaK of M. pneumoniae belong to the class of multi-binding proteins described in other bacterial species (Kainulainen and Korhonen 2014) . In general, the complex of ECM proteins is involved in many aspects of host tissue integrity and signaling (Hynes 2009 ). Using human Fc, Fn, Ln, Lc and Vc as binding partners of microbial proteins, it has been suggested that bacteria influence important processes that determine the colonization success such as adhesion, tissue invasion and evasion of the host immune response (Gonzalez-Chavez, Arévalo-Gallegos and Rascón-Cruz 2009; Henderson, Nair and Pallas 2011; Singh, Su and Riesbeck 2010; Chagnot et al. 2012; Singh et al. 2012; Morgenthau et al. 2013) .
In contrast to chaperones in other bacterial species (Henderson, Allan and Coates 2006; Götz et al. 2015) , GroEL and DnaK of M. pneumoniae were not secreted in the supernatant of bouillon cultures (data not shown). This fact suggests stable anchoring of the chaperones in the cell membrane. Therefore, it can be hypothesized that possible interactions with host factors are linked to intact mycoplasmal cells. Furthermore, in sera of guinea pigs intranasally infected with freshly grown M. pneumoniae cells (natural route of infection), specific antibodies to GroEL and DnaK were not detected (data not shown). This is in agreement with most of the surface-displayed glycolytic enzymes of M. pneumoniae , indicating the accessibility of small and/or non-immunogenic parts of the proteins.
Future experiments will have to show how the (multiple) interaction of these surface-displayed protein regions with host factors is organized on the molecular level. Previous studies investigating the binding regions of surface-localized proteins PdhB (Thomas, Jacobs and Dumke 2013) and EF-Tu (Balasubramanian, Kannan and Baseman 2008) of M. pneumoniae found one and two distinct Fc and Plg interaction sites. Furthermore, a few amino acid changes in EF-Tu proteins of the closely related species M. pneumoniae and M. genitalium are responsible for binding or non-binding to host proteins (Balasubramanian et al. 2009 ). Summarizing these data, demonstration of surface localization of a bacterial protein and in vitro binding to human factors are preconditions for a predicted influence on hostpathogen interaction processes but experimental determination of the binding sites of bacterial proteins and their surface display will provide greater insight into the in vivo relevance of this binding.
Strong interactions between bacterial proteins and human Plg and Vc were confirmed not only for both chaperones investigated here but also for all surface-displayed glycolytic enzymes of M. pneumoniae and for whole mycoplasmal cells , whereas the binding characteristics of other ECM factors are more variable. Recently, a conserved region of Vc was reported as responsible for interaction with different pathogens (Hallström et al. 2016) . Future experiments are necessary to confirm this mechanism in M. pneumoniae. Additionally, the binding potential of Kringle domains of human Plg to lysine of interaction partners is well documented (Bhattacharya, Ploplis and Castellino 2012; Sanderson-Smith et al. 2012) . The strong influence of pretreatment of Plg with ACA and with the amino acids lysine and arginine (data not shown) on binding to recombinant GroEL and DnaK confirms the importance for the interaction of abundant lysine residues in bacterial proteins. This is in agreement with surface-localized glycolytic enzymes . However, lysine-independent Plg binding was demonstrated for a defined part of M. pneumoniae PdhB (Thomas, Jacobs and Dumke 2013) . It can be assumed that the formation of a layer of different Plg-binding proteins on the bacterial surface guarantees the stable acquisition of this host factor. Since binding of Plg to recombinant GroEL and DnaK in the presence of human cells allows the generation of plasmin (Fig. 6) , these interactions may result in an increase of the proteolytic activity of the pathogen-Plg complex. Degradation of host factors by bacterial proteins and activated Plg was confirmed in different studies for Fc, Fn and Vc (Lähteenmäki, Kuusela and Korhonen 2000; Vieira et al. 2009; Sanderson-Smith et al. 2012; Gründel, Jacobs and Dumke 2016) . In addition, this study demonstrated quantitative differences in plasmin generation depending on the host activator used. This is in accordance with a previous report investigating pneumococcal phosphoglycerate kinase (Fulde et al. 2014) .
Ongoing investigations determining the functional anchoring of DnaK and GroEL in the cell membrane of M. pneumoniae are also of potential interest for vaccine development to prevent infections in risk populations. Previous studies reported that anti-GroEL and anti-DnaK have protective properties in different species such as M. gallisepticum, Bacillus anthracis or Salmonella typhi (Bansal et al. 2010; Sinha and Bhatnagar 2013; Paliwal et al. 2011; Tan et al. 2015) . With regard to the lack of detection of specific antibodies to DnaK and GroEL in guinea pigs infected with M. pneumoniae, exact determination of surface-displayed regions of both proteins is a precondition for further efforts in this direction.
In conclusion, the results of this study confirm that the chaperones GroEL and DnaK belong to the cytosol-and surfacelocalized proteins of the human pathogen M. pneumoniae. Additionally, the in vitro interaction of both proteins with different components of the human ECM and with Plg as well as Plg activation in the presence of recombinant proteins imply a potential role of GroEL and DnaK in the adhesion and dissemination processes during M. pneumoniae infections. 
